A Systematic Review and Meta-Analysis on the Safety of Vascular Endothelial Growth Factor (VEGF) Inhibitors for the Treatment of Retinopathy of Prematurity.
<h4>Introduction</h4>Laser photocoagulation is the current gold standard treatment for proliferative retinopathy of prematurity (ROP). However, it permanently reduces the visual field and might induce myopia. Vascular endothelial growth factor (VEGF) inhibitors for the treatment of ROP m...
Saved in:
Main Authors: | Laura Pertl, Gernot Steinwender, Christoph Mayer, Silke Hausberger, Eva-Maria Pöschl, Werner Wackernagel, Andreas Wedrich, Yosuf El-Shabrawi, Anton Haas |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0129383 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical Course and Results of Anti-VEGF Therapy of Retinopathy of Prematurity
by: L. A. Katargina, et al.
Published: (2021-04-01) -
Screening for Retinopathy of Prematurity
by: Hartnett, Claire, et al.
Published: (2011) -
Retinopathy of Prematurity. Review
by: N. V. Popova, et al.
Published: (2021-10-01) -
Deep learning applications for diabetic retinopathy and retinopathy of prematurity diseases diagnosis: a systematic review
by: Elizabeth Ndunge Mutua, et al.
Published: (2025-08-01) -
The level of VEGF-A in the lacrimal fluid of diabetic retinopathy
by: Yu. A. Borzilova, et al.
Published: (2015-12-01)